World

US to pay Pfizer, BioNTech $1.95 billion for 100 million Covid-19 vaccine doses

38Views

Issued on:

Pfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of theirCovid-19 vaccine candidate.

Advertising

Read more

The agreement allows the U.S. government to acquire an additional 500 million doses, the Department of Health and Human Services and the Department of Defense said.

Pfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, after completing demonstration of safety and efficacy in a large Phase 3 clinical trial.

A vaccine is seen as crucial to tackle the pandemic and governments across the globe have signed deals with drugmakers to secure dosages of their vaccine candidates.

Pfizer and BioNTech are among a handful of companies that areRead More – Source